Cognition Therapeutics
CGTX
31 hedge funds and large institutions have $13.9M invested in Cognition Therapeutics in 2022 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 7 reducing their positions, and 4 closing their positions.
75% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 4
22% more capital invested
Capital invested by funds: $11.4M → $13.9M (+$2.48M)
14% more repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 7
11% more funds holding
Funds holding: 28 → 31 (+3)
9.2% more ownership
Funds ownership: 22.96% → 32.16% (+9.2%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PFO
Pathstone Family Office
Englewood,
New Jersey
|
+$4.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
+$688K |
| 3 |
CC
Carlson Capital
Dallas,
Texas
|
+$208K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$136K |
| 5 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
+$104K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$407K |
| 2 |
PM
Prosight Management
Dallas,
Texas
|
-$254K |
| 3 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
-$234K |
| 4 |
VC
Voss Capital
Houston,
Texas
|
-$188K |
| 5 |
PWM
Perigon Wealth Management
San Francisco,
California
|
-$179K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Northern Trust
Chicago,
Illinois
| $27K | +$29.4K | +14,116 | New |
|
|
IA
27
IFP Advisors
Tampa,
Florida
| $10K | – | – | – |
|
28
UBS Group
Zurich,
Switzerland
| $6K | +$4.76K | +2,286 | +254% |
|
|
BCA
29
Bray Capital Advisors
Naples,
Florida
| $4K | – | – | – |
|
|
TRCT
30
Tower Research Capital (TRC)
New York
| $2K | -$2.02K | -970 | -51% |
|
|
NCM
31
Nantahala Capital Management
New Canaan,
Connecticut
| – | -$407K | -192,752 | Closed |
|
|
PM
32
Prosight Management
Dallas,
Texas
| – | -$254K | -120,198 | Closed |
|
|
BRF
33
B. Riley Financial
Los Angeles,
California
| – | -$65K | -30,904 | Closed |
|
34
Two Sigma Advisers
New York
| – | -$33K | -15,600 | Closed |
|
35
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | +$233 | +112 | New |
|
CGTX Hedge Fund Activity: Q3 2022 in Review
31 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Cognition Therapeutics (CGTX) for Q3 2022, worth a combined $13.9M — up 22% from $11.4M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new CGTX positions and 4 closed out — a net gain of 3 holders — while 8 added to existing stakes and 7 trimmed.
The largest buyer was Pathstone Family Office, adding an estimated $4.6M. The largest seller was Nantahala Capital Management, exiting entirely with an estimated $407K sold.
- 31 institutional investors held Cognition Therapeutics (CGTX) as of Q3 2022, up from 28 in Q2 2022.
- Funds reported $13.9M of Cognition Therapeutics stock for Q3 2022, up 22% quarter-over-quarter.
- 7 funds opened new Cognition Therapeutics positions in Q3 2022 and 4 closed out, a net change of +3 holders.
- The largest Cognition Therapeutics buyer in Q3 2022 was Pathstone Family Office, an estimated $4.6M added.
- The largest Cognition Therapeutics seller in Q3 2022 was Nantahala Capital Management, an estimated $407K sold.
Based on aggregated 13F filings for Q3 2022.